Skip to content
The Nexus
DossierENTITY

Daphne Zohar

Coverage of Daphne Zohar in the Nexus archive.

Earliest in view: May 7 · 18:15 UTCMost recent: May 7 · 18:15 UTC
Co-mentioned in this coverage
Seaport Therapeuticsorganization1Eli Lillyorganization1Novo Nordiskorganization1Marty Makaryperson1Cytokineticsorganization1
Recent coverage
  • HEALTHMay 7 · 18:15 UTCSTAT NEWS
    Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles

    Seaport Therapeutics CEO Daphne Zohar discusses the company's successful IPO, while notable news includes an obesity pill battle between Eli Lilly and Novo Nordisk, and FDA Commissioner Marty Makary faces White House troubles. This is the 400th episode of a biotech podcast. The episode covers various biotech news including a Phase 3 study win for Cytokinetics.